Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by n1urrw12on Dec 30, 2017 10:44am
242 Views
Post# 27250910

Howard; you have some explaining to do

Howard; you have some explaining to doAs pointed out by some astute members of this board how can you put out a NR Dec.29 stating Wanbang is filing for IND ;when in fact according to Chineese NR it was filed in Nov, and received approval Dec.26 for clinical trials. Totally misleading and unacceptable.
The filing in Nov. should have been materal news.
I personally think their hand was forced to put out a release on Friday because one of our members(Bazooka I believe) discovered the Chineese NR of Dec.26
At the very least there should have been volume on the stock based on the news; but the timing of the release(Friday during holidays) was a non event and noticed by very few. Not sure if next week will bring in renewed interest or not.
C'mon Management ;make a New years Resolution to get your facts straight and line up a PR firm that can create interest on significant news
Bullboard Posts